ANGEN FINANCIAL STATEMENTS

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. — balance sheet, income statement and cash flow trends

ANGENAnatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S.

🇹🇷 Turkey · IS · Healthcare · Medical Devices

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue783.4 M ₺+11.7%

Gross Profit460.6 M ₺+9.2%

Operating Income-83.9 M ₺-238.8%

EBITDA76.8 M ₺-62.7%

Net Income-352.8 M ₺—

Peer Comparison· Medical Devices

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
ANGEN	11.7%	58.8%	9.8%	-45.0%
LUNG	1.2%	75.5%	-54.5%	-60.1%
TELA	13.5%	67.3%	-40.2%	-49.3%
ARAY	-7.9%	26.8%	-1.5%	-10.8%
OM	2.0%	40.6%	-48.6%	-63.7%
NNOX	25.7%	-87.7%	-336.6%	-523.8%
Industry median	7.4%	58.9%	5.2%	-5.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity1.7 B ₺67%
Current Liabilities326.9 M ₺13%
Long-term Liabilities526.7 M ₺20%

Key Figures

YoY change

Total Assets2.6 B ₺+37.2%

Total Liabilities853.6 M ₺+202.1%

Total Equity1.7 B ₺+8.3%

Cash & ST Investments128.7 M ₺-31.8%

Total Debt490.6 M ₺+879.7%

Net Debt361.9 M ₺—

Peer Comparison· Medical Devices

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
ANGEN	2.31	28.1%	4.71	67.2%
LUNG	4.91	123.0%	0.11	38.1%
TELA	3.61	-1,084.3%	-0.52	-7.4%
ARAY	1.42	437.3%	-22.14	9.3%
OM	6.29	91.0%	0.96	44.8%
NNOX	3.64	6.0%	0.74	86.6%
Industry median	3.28	44.7%	0.82	49.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow315.2 M ₺+73.7%

Capital Expenditures-481.6 M ₺—

Free Cash Flow-166.4 M ₺—

Dividends Paid0 ₺—

Peer Comparison· Medical Devices

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
ANGEN	40.2%	-21.2%	61.5%	-89.3%
LUNG	-33.1%	-33.3%	0.2%	55.1%
TELA	-36.7%	-37.4%	0.7%	74.5%
ARAY	-4.5%	-6.8%	2.3%	41.4%
OM	-28.5%	-29.1%	0.6%	44.8%
NNOX	-313.5%	-351.8%	38.3%	59.8%
Industry median	7.2%	1.5%	4.1%	76.6%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ANGEN

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 3, 26. This content is for informational purposes only and is not investment advice.